Total Payments
$9,536
2024 Payments
$449.50
Companies
32
Transactions
167
Medicare Patients
816
Medicare Billing
$248,632
Payment Breakdown by Category
Food & Beverage$9,440 (99.0%)
Education$95.49 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,440 | 157 | 99.0% |
| Education | $95.49 | 10 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,403 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,215 | 15 | $0 (2024) |
| Amarin Pharma Inc. | $1,048 | 15 | $0 (2019) |
| Abbott Laboratories | $519.55 | 5 | $0 (2022) |
| Gilead Sciences, Inc. | $466.65 | 16 | $0 (2018) |
| GlaxoSmithKline, LLC. | $342.05 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $335.67 | 4 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $275.60 | 6 | $0 (2024) |
| Radius Health, Inc. | $255.91 | 4 | $0 (2021) |
| PFIZER INC. | $221.83 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.50 | 11 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $938.66 | 19 | GlaxoSmithKline, LLC. ($301.66) |
| 2022 | $132.06 | 3 | Abbott Laboratories ($78.52) |
| 2021 | $368.96 | 3 | AstraZeneca Pharmaceuticals LP ($250.00) |
| 2020 | $347.08 | 5 | AbbVie Inc. ($254.36) |
| 2019 | $2,112 | 25 | AbbVie, Inc. ($802.71) |
| 2018 | $2,078 | 36 | AbbVie, Inc. ($757.37) |
| 2017 | $3,109 | 65 | Amarin Pharma Inc. ($478.94) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Gastroenterology | ||||||
| 06/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Gastroenterology | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Gastroenterology | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: Cardio-renal | ||||||
| 04/24/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Inflammation | ||||||
| 01/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Cardio-renal | ||||||
| 01/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardio-renal | ||||||
| 01/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Gastroenterology | ||||||
| 12/07/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $117.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/07/2023 | AbbVie Inc. | LINZESS (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/30/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Cardio-renal | ||||||
| 11/07/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardio-renal | ||||||
| 11/01/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.86 | General |
| 09/22/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: Ophthalmology | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: Cardio-renal | ||||||
| 08/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 215 | 1,075 | $223,201 | $70,306 |
| 2022 | 3 | 163 | 1,037 | $210,920 | $67,042 |
| 2021 | 3 | 163 | 955 | $194,800 | $63,281 |
| 2020 | 5 | 275 | 974 | $217,560 | $48,002 |
Total Patients
816
Total Services
4,041
Medicare Billing
$248,632
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 166 | 1,026 | $208,001 | $66,065 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $15,200 | $4,241 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 1,005 | $202,720 | $65,416 | 32.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $6,600 | $1,097 | 16.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $1,600 | $529.44 | 33.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 141 | 931 | $186,400 | $62,268 | 33.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 12 | $7,200 | $783.12 | 10.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 12 | $1,200 | $230.28 | 19.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 833 | $167,760 | $43,570 | 26.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 46 | 48 | $27,700 | $2,884 | 10.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 60 | 62 | $11,700 | $1,173 | 10.0% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 16 | 16 | $8,900 | $313.28 | 3.5% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2020 | 15 | 15 | $1,500 | $61.56 | 4.1% |
About Dr. Benjamin Truong, MD
Dr. Benjamin Truong, MD is a Primary Care healthcare provider based in Rosemead, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801891452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Truong, MD has received a total of $9,536 in payments from pharmaceutical and medical device companies, with $449.50 received in 2024. These payments were reported across 167 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,440).
As a Medicare-enrolled provider, Truong has provided services to 816 Medicare beneficiaries, totaling 4,041 services with total Medicare billing of $248,632. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Rosemead, CA
- Active Since 06/19/2005
- Last Updated 06/01/2016
- Taxonomy Code 261QP2300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801891452
Products in Payments
- Creon (Drug) $1,057
- Vascepa (Drug) $1,048
- FARXIGA (Drug) $562.21
- CREON (Drug) $272.69
- Tymlos (Biological) $255.91
- ICDs (Device) $237.29
- Vemlidy (Drug) $226.05
- ENTRESTO (Drug) $219.13
- Trulance (Drug) $217.69
- BEVESPI AEROSPHERE (Drug) $214.35
- Livalo (Drug) $214.16
- SOLIQUA (Drug) $212.31
- IBSRELA (Drug) $194.41
- BRILINTA (Drug) $193.23
- Ranexa (Drug) $190.52
- JARDIANCE (Drug) $189.93
- XIFAXAN (Drug) $175.60
- Kerendia (Drug) $153.38
- VIBERZI (Drug) $146.00
- LINZESS (Drug) $141.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.